2023 International Congress Archives - Page 79 of 186

Racial and Ethnic Differences in Suicidal Ideation in North American patients with Huntington’s Disease: Analysis using the ENROLL-HD Dataset

A. Mendizabal, Y. Bordelon, S. Perlman (Los Angeles, USA)
Radiological markers of CSF α-synuclein aggregation in Parkinson’s disease patients

A. Droby, A. Yoffe-Vasiliev, K. Fraser, O. Mabrouk, B. Cohen, N. Omer, A. Bar Shira, M. Gana-Weisz, O. Goldstein, R. Alcalay, A. Orr-Urtreger, J. Shirvan, J. Cedarbaum, N. Giladi, A. Mirelman, A. Thaler (Tel-Aviv, Israel)
Ramelteon ameliorates abnormal sleep-wake behavior in a zebrafish model of Parkinson’s disease by facilitating abnormal lipid metabolism

F. Wang, MZ. Pang, JY. Liu, CF. Liu (Suzhou, China)
Randomized Controlled Trial comparing continuous intrajejunal levodopa infusion and deep brain stimulation for Parkinson’s disease. Cost-effectiveness and cost-utility outcomes of the INVEST study

D. van Poppelen, M. van Barreveld, R. de Bie, P. Schuurman, F. van Delft, G. Geurtsen, R. de Haan, M. Dijkgraaf, J. Dijk (Amsterdam, Netherlands)
Randomized, waitlist-controlled trial of Karate Intervention to Change Kinematic Outcomes in PD (KICK OUT PD)

J. Fleisher, K. Woo, B. Sennott, J. O'Keefe, C. Gill, S. Anderson, N. Purcell, B. Ouyang, J. Chodosh (Chicago, USA)
Rapid cognitive decline and new-onset psychosis after GPi DBS in a severe GBA mutation carrier: a case demonstrating the importance of genetic screening pre-DBS

V. Palakuzhy, M. Rosenbaum, J. Fleisher, V. Patron, D. Gonzalez, M. Afshari, G. Pal (Chicago, USA)
Rapidly progressive dementia – catatonia – myoclonus in 80 years old patient: An unusual case

DAN. Rebolledo Garcia, ART. Cadena Fernandez, ANA. Michel Chavez, JUA. Calderon Martinez, HOR. Senties Madrid, GRI. Romero Sanchez (Mexico City, Mexico)
Rapidly progressive fatal dystonia in an adult.

D. Joshi, A. Kumar, S. Parida, S. Pattanayak (Varanasi, India)
Rare genetic and clinical presentation of SPG7-related Hereditary Spastic Paraplegia.

J. Hickman, E. Forbes, J. Feuerstein (DENVER, USA)
Rasagiline in Chinese patients with early-stage parkinson’s disease: a randomized, double-blind, placebo-controlled, delayed-start trial

W. Su, HJ. Liu, LJ. Wang, QY. Ye, L. Cao, HY. Zhou, XG. Luo, ZT. Ding, T. Wang, Q. Wang, HZ. Ma, EH. Xu, HB. Chen (Beijing, China)
Reaching kinematics in patients with Spinocerebellar Ataxia Type 12 using a markerless motion tracking system

ABB. Bayen, SC. Choudhury, SM. Majumdar, PB. Basu, MRB. Baker, SNB. Baker, H. Kumar (KOLKATA, India)
Reaching the hard-to-reach: the representativeness of patients with parkinsonism recruited to the PRIME-UK cross-sectional study

E. Tenison, M. Smith, D. Pendry-Brazier, A. Cullen, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
Real-life heart rate assessment: a digital biomarker for autonomic dysfunction in early Parkinson’s disease?

K. Veldkamp, L. Evers, Y. Raykov, M. Little, M. Brouwer, B. Bloem, J. Thannhauser (Nijmegen, Netherlands)
Real-life monitoring of Parkinson’s disease tremor: does the non-tremor subtype really exist?

R. Terranova, L. Evers, D. Soriano, Y. Raykov, M. Little, H. Cagnan, B. Bloem, R. Helmich (Catania, Italy)
Real-world effectiveness and safety of deutetrabenazine in patients with chorea associated with Huntington disease

V. Sung, A. White, H. Romdhani, D. Goldschmidt, R. Ayyagari, N. Chaijale, A. Yaari, M. Gordon, J. Logan, A. Yang, R. Ribalov (Birmingham, USA)
Real-World Outcomes with Directional Deep Brain Stimulation (DBS) Systems: Awake versus Asleep Lead Placement

J. Vesper, G. Deuschl, L. Chen, R. Jain (Düsseldorf, Germany)
Real-world retrospective safety analysis of onabotulinumtoxinA for the treatment of patients with concurrent cervical dystonia and chronic migraine

C. Rhyne, K. Martinez, J. Stoilova, A. Patel, K. Becker Ifantides, R. Singh, I. Yushmanova, M. Sadeghi, S. Battucci, G. Forde (Chicago, USA)
Real-world utility of MANAGE PD tool by physicians and patients in Germany

M. Südmeyer, D. Pedrosa, F. Siebecker, C. Arlt, J. Kopra, W. Jost (Potsdam, Germany)
Real-World Utilization of Istradefylline Among Patients with Parkinson’s Disease

M. Rezak, J. Qian, Y. Zhao, A. Silverstein, J. Chamber, J. Swindle, N. Kronfeld, P. Lewitt (Hoffman estates, USA)
Recommendations to tackle under-recognition and under-treatment of sialorrhea in Parkinson’s Disease: Is it time for a paradigm shift?

B. Bergmans, V. Clark, S. Isaacson, T. Bäumer (Bruges, Belgium)
Reconstruction of the dentato-rubro-thalamic tract based on the anatomy of the rubral wing

A. Berger, J. Chung, Z. Schnurman, L. Pan, T. Shepherd, A. Mogilner (New York, USA)
Recruiting for Parkinson’s disease risk: Successful engagement tactics to screen for hyposmia in undiagnosed individuals

M. Kuhl, R. Dobkin, L. Lemon, C. Destro, C. Kelliher, T. Rosenbaum, N. Islam, K. Lynch, L. Heathers, M. Totten, E. Bryan, C. Stanley, C. Hobbick, B. Mcmahon, K. Fabrizio, K. Marek (New York, USA)
Recruiting people at risk of Parkinson’s disease: comparative data from PPMI Online and HeBA Kassel

E. Brown, S. Schade, S. Ghosh, K. Rege, V. Satagopam, M. Marti, W. Poewe, R. Kruger, C. Trenkwalder, L. Chahine, R. Dobkin, D. Weintraub, E. Tolosa, C. Marras, E. Bryan, J. Valverde Twiggs, M. Korell, K. Marek, B. Mollenhauer, C. Tanner (San Francisco, USA)
Recruitment of Parkinson’s disease patients with mild-to-moderate anxiety into a randomized controlled trial: Experience of a large Canadian tertiary movement disorders clinic

J. Lam, J. Zhu, D. Meng, P. Uzelman, S. Appel-Cresswell (Vancouver, Canada)
Reduced non-REM sleep in Parkinson disease is associated with memory impairment and non-motor symptom burden

S. Shah, C. Dintino, S. Lageman, N. Mukhopadhyay, E. Shelton, S. Holden, J. Broussard, L. Cloud, M. Barrett, B. Berman (Richmond, USA)
Reductions in OFF time with ND0612 for patients with Parkinson’s disease experiencing motor fluctuations: Responder-analysis from an open-label Phase 2 study

A. Ellenbogen, A. Espay, S. Isaacson, N. Lopes, N. Sasson, T. Yardeni, W. Poewe (Farmington Hills, USA)
Referral patterns from primary care physicians to specialists among people with Parkinson’s disease or a Parkinson’s disease–related disorder

A. Patel, K. Jinnett, A. Gaur, E. Mearns, B. Cobb, C. Macaluso, J. Weiss, H. Lin, N. Win (South San Francisco, USA)
refractory myoclonus after COVID-19 with resolution after corticosteroids; a case report with brain biopsy and serial neuroimaging.

E. Marandi, M. Gates, H. Patel, P. Hanna, W. Ma (Edison, USA)
Regional Atrophy and Motor Speech in PSP

H. Clark, J. Stierwalt, F. Ali, H. Botha, K. Josephs, J. Whitwell (ROCHESTER, USA)
Regional brain volume and cognitive alterations in Huntington’s Disease Patients

M. Garon, L. Weis, L. Lerjefors, F. Pistonesi, V. Cianci, N. Cazzola, ML. Nasi, G. Bonato, D. Cecchin, M. Carecchio, A. Antonini, R. Biundo (padova, Italy)
Regional Pain Syndromes- A potential clinical biomarker of Prodromal Parkinson’s Disease

M. Kumar (Kharagpur, India)
Rehabilitation robot-assisted gait training for Parkinson’s disease: A systematic review and meta-analysis of its effects on lower extremity dyskinesia and motor function

M. Elfaituri, T. Khaled, A. Benghatnsh (Tripoli, Libya)
Relationship between agricultural vulnerability to organic compound fungicides and herbicides and Parkinson’s disease incidence in rural population in northern India

R. Kumari, A. Rao, A. Gaur (Delhi, India)
Relationship between balance performance and corticomotor Inhibition in individuals with Parkinson’s disease

HH. Liu, YR. Yang, YL. Ling, RY. Wang, SJ. Cheng (Taipei City, Taiwan)
Relationship between bradykinesia and cognitive functions in patients with essential tremor

G. Paparella, L. Angelini, R. Margiotta, A. Cannavacciuolo, D. Costa, D. Birreci, M. de Riggi, M. Passaretti, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)
Relationship between postural and kinetic tremor control with VIM-DBS in Essential Tremor

R. Butler, M. Blumenfeld, A. Brinda, M. Bryants, D. Sullivan, S. Pandey, J. Vitek, L. Schrock, K. Gagesch, K. Domingo, T. Orcutt, J. Matsumoto, S. Cooper, M. Johnson (Minneapolis, USA)
Relationship between sleep quality, fear of fall and falls history in people with Parkinson’s disease

N. Alissa, R. Rehan, A. Al-Sharman, M. Sirine Latrous, A. Aburub, K. El-Salem, L. Morris, H. Khalil ()
Relationship between the Montreal Cognitive Assessment and clinical gait assessments in individuals with Parkinson disease

A. Boddy, K. Barta, L. Perry, M. Flores, K. Sawyer, A. Campbell (St Augustine, USA)
Relationship of health-related quality of life (HRQoL) patterns with clinical diagnosis in patients with spinocerebellar ataxia (SCA) – A latent class analysis

M. Buchholz, N. Weber, T. Klockgether, B. Michalowsky (Greifswald, Germany)
Relevance of amyloid deposition for REM sleep behavior disorder in Parkinson’s disease

J. Pineda-Pardo, M. López-Aguirre, G. Pagano, V. Gnoni, K. Ray Chaudhuri, G. Logroscino, D. Urso (Madrid, Spain)
Reliability and validity of automatedly generated vowel space metrics as biomarkers of articulatory impairment severity and progression in early Parkinson’s Disease

D. Kwaśny, J. Rusz, R. Ullmann, E. Volkova-Volkmar, B. Fehlmann, S. Lambrecht, G. Pagano, T. Kustermann, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)
Reliability of brainsense technology as compared to SoC in STN DBS programming

I. Avilés-Olmos, L. Gonzalez-Quarante, A. Arcadi, P. Clavero, MC. Rodriguez-Oroz, M. Valencia, M. Alegre (Pamplona, Spain)
Reliability of Indonesian Version Wearing Off Questionnaire

R. Pinzon (Yogyakarta, Indonesia)
Reliability of the severity subscale of the Toronto Western Spasmodic Torticollis Rating Scale in a multidisciplinary team

S. Kassaye, W. de Hertogh, S. de Waele, D. Crosiers, E. Gudina, J. de Pauw (Molenstraat 56, Belgium, Ethiopia)
REM sleep behavior disorder in Parkinson´s Disease: a risk factor for Impulse Control Disorders.

M. Vales Montero, A. Contreras Chicote, B. Delacasa Fages, J. Pérez Sánchez, E. Luque Buzo, M. González Sánchez, F. Grandas (Madrid, Spain)
REM sleep behaviour disorder in Parkinson’s disease: prevalence and correlation with other sleep parameters

S. Diaconu, L. Ungureanu, A. Zarnoveanu, B. Ciopleias, V. Vasile, A. Iacob, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)
Remote monitoring of physical activity in Progressive Supranuclear Palsy (PSP) using wearable sensors

AM. Wills, R. Mishra, M. Sharma, AJ. Hall, J. Casado, R. Cole, A. Vaziri, A. Pantelyat (Boston, USA)
Repetitive trans-spinal magnetic stimulation and kinesiotherapy could reduce motor and gait symptoms in patients with neurodegenerative ataxia?

C. Souza, L. Lopes, J. Oliveira, S. Casagrande, C. Tanaka, E. Barbosa, R. Cury (Sao Paulo, Brazil)
Representation of movement repertoire in subthalamic neural circuits using a markerless 3D behavioral tracking system.

JH. Shin, HY. Jeon, B. Jin, SM. Lee, JH. Kim, JS. Yook, JH. Kim, B. Jeon (Seoul, Republic of Korea)
Reproductive life factors and sex hormones in post-menopausal female patients with Parkinson’s Disease

R. Bovenzi, M. Conti, G. Sancesario, R. Cerroni, M. Pierantozzi, A. Stefani, N. Mercuri, T. Schirinzi (Rome, Italy)
Repurposing the MDS-UPDRS part III for early-stage Parkinson’s disease: Supportive evidence for a bradykinesia and rigidity specific sub-score

M. Key Prato, A. Regnault, S. Quéré, N. Massat, A. Benoit, T. Morel (Brussels, Belgium)
Resolving missing data from the MDS-UPDRS: implications for telemedicine

S. Luo, C. Goetz, D. Choi, S. Aggarwal, T. Mestre, G. Stebbins (Durham, USA)
Response of extraocular movements in parkinson’s disease to levodopa: an electrooculographic perspective

S. Patel, C. Sankhla, R. Savaj (Mumbai, India)
Response to Levodopa in Parkinson´s Disease Over Time. A 4-year Follow-up Study.

D. Santos García, T. de Deus, C. Cores, M. Feal Painceiras, I. García-Díaz, M. íñiguez, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, F. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)
Rest Tremor in Parkinson’s Disease Is Associated with Increased Ipsilateral DAT Binding

K. Niemi, J. Sunikka, V. Kaasinen, J. Joutsa (Turku, Finland)
restless leg syndrome in parkinson’s disease patients: prevalence and correlates with sleep parameters

S. Diaconu, R. Zosin, L. Irincu, E. Ungureanu, A. Zarnoveanu, V. Vasile, M. Cusnir, N. Enache, C. Falup-Pecurariu (Brasov, Romania)
Restless legs syndrome may be associated with freezing of gait, start hesitation and falls in Parkinson’s disease

M. Isayan, H. Hovakimyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)
Results from IRL790C005 – A Randomized, Double-Blind, Placebo-Controlled Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily On-Time without Troublesome Dyskinesia in Patients with Parkinson’s Disease

A. Antonini, S. Waters, C. Sonesson, J. Landström, N. Waters, J. Tedroff (Padova, Italy)
Reticulospinal tract integrity in patients with SCA12 having impairment of Corticospinal tract- a clinical and electrophysiological study

SC. Choudhury, ABB. Bayen, SM. Majumdar, PB. Basu, MRB. Baker, SNB. Baker, HK. Kumar (Kolkata, India)
Retrospective exploration of the 5-2-1 criteria in clinical practice

M. Karlstedt, A. Johansson (Stockholm, Sweden)
Review of NPO status on admitted PD patient outcomes

R. Martin (Springfield, USA)
Risk and protective factors in Parkinson’s disease: a simultaneous and prospective study with linear and machine learning models

MI. de Bartolo, A. Gialluisi, S. Costanzo, D. Belvisi, S. Falciglia, M. Ricci, A. Di Castelnuovo, T. Panzera, MB. Donati, G. Fabbrini, G. de Gaetano, A. Berardelli, L. Iacoviello (Pozzilli, Italy)
Risk factors for Freezing of Gait in Parkinson’s Disease: A Systematic Review and Meta-analysis

X. Zheng, J. Liu, S. Wang, R. Ou, C. Li, H. Shang (Chengdu, China)
Risk Factors for Stimulation-Induced Bradykinesia in Dystonia Patients Treated with Deep Brain Stimulation: A Retrospective Analysis.

F. Lange, B. Karandasch, P. Mahlknecht, J. Kraus, A. Kühn, G. Deuschl, J. Volkmann, M. Reich (Würzburg, Germany)
Risk factors of sleep disordered breathing in Veterans with Parkinson’s disease.

A. Sarwar (PEARLAND, USA)
Risk of Depression after Parkinson’s disease, stroke, multiple sclerosis, and migraine in an Iranian population

F. Hojjati Pour, M. Salari, H. Pakdaman, M. Etemadifar, N. Mirjamali, M. Khalkhali, A. Farahani (Teheran, Islamic Republic of Iran)
Risk of hallucinations and amantadine treatment in levodopa-induced dyskinesia patients with Parkinson’s disease: a meta-analysis of randomized controlled trials

M. Adil, T. Ahmad, M. Sharma (New Delhi, India)
Risk of Parkinson’s Disease due to Helicobacter Pylori and High Salt Consumption

V. Balendra (Park Ridge, USA)
Risk of Parkinson’s disease in spinal cord injury: a nationwide cohort study in south Korea

JH. Ahn, KD. Han, H. Choi, W. Jung, JW. Cho, J. Youn, DW. Shin (Seoul, Republic of Korea)
RNA editing contributes to the inflammatory astrocytic response in Parkinson’s disease.

A. Wagen, K. D'Sa, M. Choi, S. Strohbuecker, G. Young, R. Reynolds, S. Garcia-Ruiz, Z. Chen, A. Ghareeb, J. Bayne, S. Rodriques, M. Horrocks, S. Gandhi, M. Ryten (London, United Kingdom)
RNF216–associated neurodegeneration: Is it a new NBIA disorder?

NS. Sriram (Banglore, India)
Role of ATP10B variants in Parkinson Disease in a southern Spanish cohort

R. Díaz-Belloso, MT. Periñan, M. Martín-Bornez, S. García-Díaz, M. Bonilla-Toribio, D. Buiza-Rueda, R. Pineda-Sánchez, L. Muñoz-Delgado, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, P. Mir, P. Gómez-Garre (Sevilla, Spain)
Role of bilateral pallidotomy in status dystonicus

K. Garg, M. Singh, R. Rajan (New Delhi, India)
Role of nanoparticles of berberine on oxidative stress in nigrostriatal tissue and neurobehavioral characteristics in rotenone induced animal model of Parkinson’s disease

R. Rajput, V. Sharma (New Delhi, India)
Role of the direct subthalamo-cerebellar tract in memory and learning: Implications for the pathophysiology of late-stage Parkinson’s Disease

V. Radhakrishnan, C. Gallea, S. Krishnan, B. Thomas, C. Kesavadas, A. Kishore (Trivandrum, India)
RT-QuIC for detection of pathological α-synuclein in the olfactory mucosa and CSF of Parkinson’s disease patients

V. Tommasini, M. Bongianni, M. Catalan, D. Perra, P. Polverino, C. Bertolotti, R. Baruca, G. Bellavita, L. Antonutti, G. Zanusso, P. Manganotti (Trieste, Italy)